CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
Flores-Toro, Joseph A., Luo, Defang, Gopinath, Adithya, Sarkisian, Matthew R., Campbell, James J., Charo, Israel F., Singh, Rajinder, Schall, Thomas J., Datta, Meenal, Jain, Rakesh K., Mitchell, DuaneLanguage:
english
Journal:
Proceedings of the National Academy of Sciences
DOI:
10.1073/pnas.1910856117
Date:
December, 2019
File:
PDF, 2.07 MB
english, 2019